274 related articles for article (PubMed ID: 35724476)
1. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of FDA approved drugs against Alzheimer's disease based on differential gene expression and protein interaction network analysis: an in silico approach.
G N S HS; Ganesan Rajalekshmi S; Murahari M; Burri RR
J Biomol Struct Dyn; 2020 Aug; 38(13):3972-3989. PubMed ID: 31543038
[TBL] [Abstract][Full Text] [Related]
3. Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
Azizan Z; Zali H; Mirmotalebisohi SA; Bazrgar M; Ahmadiani A
PLoS One; 2024; 19(5):e0304410. PubMed ID: 38809924
[TBL] [Abstract][Full Text] [Related]
4. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
5. Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor.
Nair G; Hema Sree GNS; Saraswathy GR; Marise VLP; Krishna Murthy TP
Med Oncol; 2021 Oct; 38(12):145. PubMed ID: 34687371
[TBL] [Abstract][Full Text] [Related]
6. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
Hudson ML; Samudrala R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
[TBL] [Abstract][Full Text] [Related]
9. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
10. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
11. Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer's, and diabetes.
Malar DS; Verma K; Prasanth MI; Tencomnao T; Brimson JM
Sci Rep; 2024 Feb; 14(1):4328. PubMed ID: 38383841
[TBL] [Abstract][Full Text] [Related]
12. Predicting Key Genes and Therapeutic Molecular Modelling to Explain the Association between
Hamarsha A; Balachandran K; Sailan AT; Nasruddin NS
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982508
[TBL] [Abstract][Full Text] [Related]
13. Revelation of Pivotal Genes Pertinent to Alzheimer's Pathogenesis: A Methodical Evaluation of 32 GEO Datasets.
Gns HS; Rajalekshmi SG; Burri RR
J Mol Neurosci; 2022 Feb; 72(2):303-322. PubMed ID: 34668150
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
Chatterjee P; Roy D; Rathi N
J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
[TBL] [Abstract][Full Text] [Related]
15. Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network.
Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
Biomed Res Int; 2021; 2021():1280237. PubMed ID: 34692825
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insight of the potential of geraniol against Alzheimer's disease.
Liu Y; Zhou S; Huang X; Rehman HM
Eur J Med Res; 2022 Jun; 27(1):93. PubMed ID: 35701806
[TBL] [Abstract][Full Text] [Related]
17. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
Kumar A; Tiwari A; Sharma A
Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
[TBL] [Abstract][Full Text] [Related]
18. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
19. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
20. Innovative target mining stratagems to navigate drug repurposing endeavours.
Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
